Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
79 Cards in this Set
- Front
- Back
What is the etymology of vaccine?
|
Vacca (latin for cow)
Vaccinia (latin for cow pox virus) Used to prevent smallpox (Vaccine --> Vaccinate --> Vaccinee ----------> Victim of Vaccination) |
|
What are characteristics of the ideal vaccine?
|
Inexpensive
Single dose Simple administration (i.e. oral) Stable for long periods (at cold and hot T) 100% effective Immediately effective Durable immunity 100% safe |
|
What were the millenium development goals?
|
1) ** Eradicate extreme poverty and hunger
2) Achieve universal primary education 3) Promote gender equality and empower women 4) **Reduce child mortality 5) ** Improve maternal health 6) ** Combat HIV/AIDS, malaria and other diseases 7) Ensure environmental sustainability 8) Develop a global partnership for development |
|
What are DALYs?
|
Disability Age Lost Years
|
|
What are some of the leading causes of lost DALYs?
|
1) Lower Respiratory infection
2) Diarrheal disease ... Ischaemic heart disease, cerebrovascular disease, TB, Measeles, malaria, iron-deficiency anemia, ptn-E malnutrition, tetanus, pertussis, osteoarthritis, liver cirrhosis, HIV, diabetes mellitus, asthma |
|
Describe the distribution of the global disease burden.
|
99.9% of the disease in devlopping world
Amt of disease in developed/western countries is very little ->Have a vaccine for quite a few of them 50% of developing world DALYs lost are lost due to infection diseases (vs <4% in the developed world) |
|
Look at tables/graphs
|
Look at tables/graphs
|
|
Describe the differential access to vaccines.
|
2002: Vaccines only 1.7% of total worldwide pharmaceutical costs
2004: ~34 million children didn't have access to childhood vaccines (UNICEF) 10-15 year delay in universal access for most vaccines in developing countries (vs devloped countries) |
|
How much would provision of all vaccines to all children by 2014 cost?
|
$30 billion USD
|
|
Why does full access to vaccines make good global sense?
|
Lowers burden of disease in poorest countries
Helps to reduce population growth Removes human "fuel" for epidemics and pandemics (ppl bring diseases with them when they move) Essential to achieve global goals of control or eradication (ie smallpox, measles, polio) |
|
How is technology development related to development (security)?
|
95% of global vaccine market controlled by 5 companies (GSK, Wyeth (Pfeizer), Merck, Sanofi Pasteur, Novartis)
Cost to build capacity for cGMP flu vaccine: ~60-100 million |
|
What has happened recently in technology development?
|
Developping countries such as Brazil, India, Indonesia etc are starting to develop vaccines as well
*BUT, 93% of it is still in the Western World** |
|
What happens to the map of world happiness during a pandemic?
|
It shifts
|
|
Why does it shift?
|
The countries that make the vaccines have a hold on them
Their citizens get the vaccine first, before it is sent to other countries EX: Mostly Developed countries that have influenza vaccines available |
|
When was the OKA vaccine developed?
|
Late 1960's in Japan
|
|
What happened to the vaccine industry during the development of varicella vaccines (vs chicken pox)?
|
2 major vaccine companies bought the right to the OKA vaccines
They agreed to divide the world in 2 (western and eastern hemispheres) NO ONE WANTED AFRICA |
|
What did Company A try and do?
|
Rushed to market a thermo-labile vaccine (needed -80 C)
Licensed vaccine in Canada in 1999 |
|
What did company B do?
|
Spent more time and developed a thermo stable vaccine that only needed to be stored at -20 C
|
|
What was the agreement upon which the 2 companies had decided to market their products?
|
10 years exclusive market agreement for each company in their half of the world
|
|
What is the sequence of events leading to varicella licensure in Canada?
|
1999: Company A licenses vaccine in Canada
1999: Canadian consensus conference recommmends universal use of varicella vaccine as soon as the thermo stable product is available 2000: Company B licenses thermo-stable vaccine in Canada 2001: Company A sues Company B in US court to prevent sales of vaccine in Canada (wins) 2003: 10 year exclusive market aggreement expires 2003: Company B begins to sell vaccine in Canada 2003: Company A licenses "thermo-stable" vaccine in "Canada |
|
What has the goal of vaccination been in the past? (1600-2000)
|
Eradicate organism: smallpox, measles, polio
Prevent infection/colonization: -Age restriction: BCG, H influenza -Sex limited: Rubella Prevent consequenes of infection -Colonization OK: S. pneumoniae -Antitoxin: Tetanus, diphtheria Modify disease: Measles vaccine + IgG |
|
Why don't we want a vaccine that prevents colonization of strep?
|
It's part of many ppl's natural flora
Resides in the thoat -> Only a problem when it colonizes the lungs |
|
What is sterile immunity?
|
Protects you for life
|
|
What were the vaccine types up to the mid-2000s?
|
-Black box: Put in pathogen in animals, mutate them, get animal AB
-Kill the bugs/attenuate them -Recombination of path DNA |
|
Milestones in human development
Cross Species protection |
Exposure to one species can protect you from another
-Credited to Edward Jenner for treating smallpox with cowpox, but already done in China, Turkey and Middle East |
|
Milestones in human development
Animal Passage of Defined Pathogen (18th century) |
Found rabies could be passed from one animal to another
Dev'p first vaccines for rabies -> Dried spinal cord taken from rabbits with rabbies -> Crushed and used to make a vaccine |
|
Milestones in human development
Germ Theory Broth Cultures (19th century) |
Germ Theory developed by Pasteur
Galtier: worked with Pasteur - Isolated bacteria on fruit/potatoes -Grow something in pure culture -Heat treat these bacteria and give to ppl -Dev'p vaccines for plague, typhoid and cholera |
|
Milestones in human development
Toxin Isolation Egg as crude cell culture (early 20th C) |
Eggs are sterile env't
Can do tissue culture Inject virus in egg/grows in large number Kill virus in egg Make vaccines Give toxins of the path -> Diphtheria, Pertussis, Tetanus -> Also BCG, Yellow Fever and Influenza (latter 2 are egg based) |
|
Milestones in human development
DNA/RNA Attenuation of Organism Basic Immunology Cell Culture (post-WWII) |
Dev'p of tissue culture
Vaccines vs viruses, etc |
|
Milestones in human development
Molecular Biology |
Almost all new vaccines use this
->Hep B etc |
|
What are the factors that drive vaccine development?
|
Fear and Massive Human Suffering
Germ theory and Sterility Egg-culture Tissue culture (1950s) Molecular Biology (1980s) Modern Immunoloy (1980s) Fear (Bioterrorism) and Massive Human Suffering (TB/AIDS) Profit |
|
What did Pasteur target?
Why? |
Chicken cholera: Economic interest, chickens were the poor man's ptn
Rabies: Infected animals and adults (mostly males) |
|
What are the factors driving vaccine development?
|
Fear and Massive Human suffering
Germ theory and sterility Egg culture Tissue culture (1950s) Molecular Biology (1950s) Modern Immunology (1980s) Fear (bioterrorism) and Massive human suffering (TB/AIDS) Profit |
|
What has happened to the vaccine industry lately?
|
Booming
Big pharma companies realized they can make billions of dollars |
|
What are the new tools in vaccine development?
|
New Ag
Adjuvants Delivery systems New Routes New Schedules |
|
What are the new Ag?
|
Subunit vaccines- multivalent vaccines
Peptide vaccines (chimeric peptides) Epitope vaccines: looked at 30,000 epitopese for HIV Conserved ptns for cross-protection: -multiple serotypes (eg pneumococcus: now have 7,9 &13 valent vaccines, but there are 90 valencies. Can we find a shared epitope betweeen them?) -Genetically labile organisms (HIV/HCV) Unique life stages to block transmission -Malaria gametocytes (blood sterilize parasite in insect so bug can't infect anyone else after) -Lyme disease: meant to work in tick's gut. Have a vaccine to target Ag in tick's gut. Cellular vaccines (personalized vaccines) |
|
What are the adjuvants?
|
-Aluminum salts (alum): has been used for a long time
-PAMPS (ex: TLR ligands like LPS, porins and CpG) -Cholera toxin B (other toxins, superAg) |
|
What are the new delivery systems?
|
DNA vaccines (CpG + intracellular delivery)
Vesicles (eg: Liposomes, ISCOMS, proteosomes) Chimeric viruses and bacterial vectors |
|
What are the new routes for vaccination?
|
Aerosol
Nasal Oral Vaginal Intradermal |
|
What are the new schedules?
|
Prime-boost strategies
|
|
Where can vaccines be administered?
|
Intranasal
Oral Intramuscular Subcutaneous Cutaneous (intadermal, epicutaneous, transdermal) Per rectum/vagina |
|
Describe skin
|
Largest "immune organ" in the body
Massive Ag exposure Critical barrier vs invasion Active surveillance: -benign vs aggressive -carefully regulated High concentraion of Langerhans cells, dermal DCs and macrophages |
|
How can an immunization be given subcutaneously?
|
Liquid jet: can even get to the muscle
Vaccine Powder: send sugar coated vaccine as a powder Hair follicle: Tape stripping: Rip hair off (arm) and rub vaccine there Micropore Colloidal carrier Ultrasound Adjuvant patch Electroporation Microneedle: give the injection to yourself, cut out the middleman, save a lot of the cost |
|
What are the immunologic concepts driving vaccine devlopment?
|
Th1/Th2 paradigm (Th0 and Th17)
DCs Immunologic priming Innate immune response |
|
Describe the Infectious disease "Paradigm" (leishmania Animal Model)
|
Infect BALBc (sensitive mice)
-> If you add Anti-IL4 or IFN-y: mouse survives (if not, mouse dies) B56BL/6 (resistant mice) -> Don't add anything, mouse lives -> Add Anti-IFNy or IL-4: mouse dies |
|
What did this show?
|
Genetically competent mice had genetically shifted
Genetically sensitive mice could have changed their phenotype |
|
What is alum?
|
Powerful Th2 adjuvant
Drives Immune response away from what we need (Th1 response because viruses are intracellular) |
|
What is DC cross-priming/cross presentation?
|
Under the right circumstances, DCs can route inactivated Ag to MHC-I presentation --> CTL
|
|
What role does DC cross presentation play in vaccination development?
|
Use dead Ag
-> No longer need to use live virus to have an IR vs intracellular path |
|
What does immune priming do?
Example? |
Directs IR
Example: If you give kids a polysac vaccine, they only make Abs If you give kids a DNA vaccine, you won't initially see anything. But then when you give them the polysac vaccine, you see that you get a more balanced response (Th1/Th2)) |
|
What is the problem with immunology in the past?
|
Was focused on Adaptive response
-> Now starting to look at the role of innate immunity |
|
What is involved in innate immunity pattern recognition?
|
PAMPs (pathogen ass't molecular patterns)
PRRs (pathogen recognition receptors) |
|
What are some PAMPs?
|
LPS
Lipoptns P/g Lipoarabinomanna Oligosacs |
|
What are some PRRs?
|
Formyl peptide resceptors
Mannose and glycan receptors (i.e. MBP) Lipopolysac binding ptn (LBP) and CD14 TLRs |
|
What does TLR3 recognize?
|
dsRNA
|
|
What are the adjuvants of the future?
|
PRRs
|
|
Why are PRRs good adjuvants?
|
Some PAMPs are intrinsic
Others can be added (classic adjuvants) Others can be engineered (chimerics) This can take advantage of in/extrinsic innate responses Take same adjuvant Depending on which ligand used, can generate a humoral or cellular response |
|
Why try to deliver the Ag as a package?
|
I.S. evolved to see array type structures (not just a little particle)
The Ag pkg does this Best way to deliver pkg: Bolus of Ag w/ structural array and a TLR stimulant |
|
What are the new uses for vaccines?
|
Many more targets:
-Intracellular organisms (TB, H pylori etc) -More complex organisms (dengue, malaria etc) -Therapeutic approaches (HBV, HPV etc) Completely new uses: -Cancer vaccines (preventative, therapeutic) -Inflammatory conditions -Contraception (sterility vaccines) |
|
What are the new targets concerning cancer?
|
Prophylactic vaccines:
-population based or targeted -p53 or known familial TAA Therapeutic vaccines: -TAAs -Adjunctive therapy, mop-up -Primary therapy Potential for double-deged sword is massive |
|
What is the double edged sword problem?
|
Some vaccines target aggressive cells: NK, CTL
Risk increases as new vaccines are developed ex: Melanoma: get a vaccine vs it but now they have another problem -> thelioma ->Autoimmune attack on the skin =>But what if the tumour is in the brain or heart? Much larger problems |
|
What is required to make a vaccine?
|
Idea
Pre-clinical Phase I-IV |
|
What happens during the pre-clinical stage?
|
Can you make the target (culture, molec bio)?
Is there an animal model Are the correlates of immunity established? Toxicity studies Cost: $1 million |
|
What happens in phase 1?
|
First in humans
Focus on safety (sneak some immunogenicity: want to see what could happen) 15-50 adult subjects Intensive monitoring Cost: $1-2 million |
|
What happens in phase II?
|
Larger numbr of subjects (300-3000)
Dose escalation (immunogenicity) First look at efficacy (sometimes) (want to see if some ppl get the disease) Studies in special populations (kids, elderly etc) Cost: $10-50 million |
|
What happens in phase III?
|
The pivotal studies
Field efficacy trials Large numbers (up to 60,000) Sometimes challenge studies Expanded populations ~100s millions |
|
What is a challenge study?
|
Example:
Give ppl malaria vaccine you're working on Grow some malaria in a colony Infect the insects with malaria Let the insects bite the ppl |
|
What happens in phase IV?
|
Post-licensure
Highly variable (depends on uptake and market forces Often done to address specific needs in one or another market) Cost: variable, but millions |
|
What are new vaccines that will come out in the future?
|
Easy ones to introduce: RSV, TB, HIV, malaria
Harder: H. pylori, Gp B strep, HSV I/II, EBV Ones that won't be easily received: UTI vaccines, "common cold" vaccines |
|
Why are some harder to introduce?
|
Some bacteria are part of our immune system, part of the normal flora
Probably not a good idea to try and get rid of them entirely |
|
What type of vaccines are the big pharmaceutical companies working on?
Why? |
UTI/Common cold ones
-Because they are very common, everyone gets them .: makes them very profitable |
|
What happens if you kill bacteria that are part of the normal flora?
|
Those areas can be colonized with pathogens
Multiresistance "intensive care" organims (cystic fibrosis) Antibiotic ass't colitis (C. dificil, started in hospitals because ppl given too many antibiotics) Vaginal yeast infections |
|
What happens if EBV is targeted?
|
EBV has a copy of human IL-10
Potent immunosuppresive agent -EBV always there at an early age If we knock out EBV, we'll KO IL-10 copy of EBV Can be very dangerous |
|
Are vaccines safe?
|
Depends on the definition
Defined as harmless: then no vaccine is safe Defined as "prevention from some other danger": then yes, very safe Need to weigh risk vs benefit |
|
Are vaccines safe enough?
|
Different q's
Rabies vaccines ---> Encephalomyetis -rabbbit spinal cord vaccine (1:200) (autoimmune T-cell mediated destruction of the brain) -Duck embryo vaccine (1:1000s) -tissue culture vaccine (none:millions) Smallpox-------> death, dissemination, ocular infection -Smallpox gone ---> vaccine too dangerous -first new case ----> vaccine ok IPV (inactive polio vaccine) ---> OPV (ocular polio vac) -Oral vaccine has live virus, causes problems, Canada has switched to IPV |
|
What is the problem with MMR (measles, mumps, rubella) vaccine?
|
Problem with measles part
Can result in major platelet decrease Cause bleeding ->1-2 kids die from this each year in Canada |
|
What is going on with the anti-vaccination sentiments?
|
People are thinking of vaccines more and more as bad (but not a new sentiment, has been happening since the timeof Jenner)
|
|
What's going to happen to anti-vaccination sentiment?
Why? |
Probably going to get worse
Every reason to expect the next generation of vaccines targeting prganisms that require CMI for prevention or clearane will be at least as problematice as the prior generations -> When something goes wrong and it ends up in the headlines, all ppl are going to see is Vaccine and Sudden death |
|
Why is the vaccine world rapidly changing?
|
Plethora of new tools
Political will + philanthropy to vaccinate all Pharma suddenly engaged ($$$) Vaccines to target cancer, chronic illness Many new players (countries, small biotechs) Regional vaccines |